Revenue ($USD) : $1,257,366,000
R&D spend : $82,728,000
Employees : 6,950
Fiscal year end : 12/31/2023
CEO : Fred Lampropoulos

www.merit.com

As longtime Merit Medical founder and CEO Fred Lampropoulos prepares to retire in 2025, the business continues to plug along. In 2024, the company received FDA clearance for its surgical guidance system, partnered with Medtronic on its unipedicular, steerable balloon catheter, and expanded its endoscopy portfolio by purchasing the EndoGastric Solutions EsophyX Z+ device for gastroesophageal reflux disease. –SW